Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Sept 2026 for IGC Pharma, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Claudia Grimaldi: trading record in brief
Claudia Grimaldi, listed as chief executive, appears in our data through filings on IGC Pharma, Inc. shares, published by SEC (Form 4). We count 8 filings; the first trade dates from 20 December 2021 and the latest from 25 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 29 September 2026 came the latest disclosure, a transaction in IGC Pharma, Inc. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Claudia Grimaldi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
150,000 shares0Common StockSEC:0001185185-26-004408:0
100,000 shares0Common StockSEC:0001185185-26-001283:0
138,462 shares@ US$0.26100.0% of flowCommon StockSEC:0001185185-26-001283:1
50,000 shares0Common StockSEC:0001185185-25-001504:0
83,333 shares0Common StockSEC:0001185185-24-000264:0
83,333 shares0Common StockSEC:0001185185-23-000672:0
83,334 shares0Common StockSEC:0001185185-22-000780:0
250,000 shares0Common StockSEC:0001185185-21-001874:0
8 of 8 declarations
